FluoroPharma Medical, Inc.
FPMI
$0.0001
$0.000.00%
OTC PK
| 12/31/2016 | 09/30/2016 | 06/30/2016 | 03/31/2016 | 12/31/2015 | |
|---|---|---|---|---|---|
| Net Income | -2.05M | -3.19M | -3.47M | -4.16M | -3.16M |
| Total Depreciation and Amortization | 44.00K | 44.20K | 43.80K | 44.60K | 46.40K |
| Total Amortization of Deferred Charges | 751.70K | 843.40K | 923.70K | 744.90K | 511.40K |
| Total Other Non-Cash Items | -1.16M | -555.60K | -787.00K | 196.70K | -650.10K |
| Change in Net Operating Assets | 1.53M | 1.13M | 1.16M | 495.50K | 579.00K |
| Cash from Operations | -880.00K | -1.73M | -2.13M | -2.68M | -2.68M |
| Capital Expenditure | -1.30K | -8.00K | -8.00K | -6.70K | -6.70K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | 0.00 | 0.00 | 36.00K |
| Cash from Investing | -1.30K | -8.00K | -8.00K | -6.70K | 29.30K |
| Total Debt Issued | 725.00K | 510.00K | 3.11M | 3.30M | 3.35M |
| Total Debt Repaid | -100.00K | -75.00K | -480.00K | -480.00K | -490.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -9.70K | 30.70K | -121.20K | -172.60K | -168.60K |
| Cash from Financing | 615.30K | 465.70K | 2.50M | 2.64M | 2.69M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -266.20K | -1.27M | 366.20K | -44.80K | 38.70K |